Uncategorized French newspaper Le Figaro publishes El País iDR24 REMEDi4ALL article Nick Sireau was getting ready to change his newborn son's diaper when he discovered a…admin28 March 2024
NewsPatientsRare Diseases University College London publishes iDR24 conference report The UCL Translational Research Office led a UCL academic delegation to join the first international…admin27 March 2024
FundersNewsPatientsRare DiseasesResources Spanish newspaper El País attends iDR24 and publishes article on untapped potential of drug repurposing Exciting insights from #iDR24! Oriol Güell from El País explores the enormous potential of drug…admin11 March 2024
News EATRIS and the REMEDi4ALL Consortium to Initiate New Study to Advance Potential Treatment for Ultra-Rare Disease Tazarotene, originally approved as a topical cream for psoriasis and acne, will be investigated as…admin13 October 2023
News REMEDi4ALL, an ambitious EU-funded research initiative, launches today to drive forward the repurposing of medicines in Europe REMEDi4ALL, an ambitious EU-funded research initiative, launches today to drive forward the repurposing of medicines…admin1 September 2022
News International partnership dedicated to repurposing of medicines is launched The repurposing of existing medicines has the potential to greatly improve public health outcomes, especially on neglected and rare…admin24 August 2022
News Existing drugs block or reduce SARS-CoV2 infection in cells Since the beginning of the pandemic, researchers worldwide have been looking for ways to treat…admin18 August 2022
News Treating COVID with antibiotics could be a much simpler way of making people better A recent study conducted in an Egyptian hospital showed that treating moderate-to-severe COVID patients with…admin12 August 2022
News Novel approach to drug repurposing incorporates two-stage prediction and machine learning A new study presents a novel approach to drug repurposing that incorporates two-stage prediction and…admin10 August 2022